Published in Eur J Oral Sci on April 01, 2008
Patient delay in presentation of possible cancer symptoms: the contribution of knowledge and attitudes in a population sample from the United kingdom. Cancer Epidemiol Biomarkers Prev (2010) 1.75
Social support, gender and patient delay. Br J Cancer (2011) 0.89
Diagnostic delay in oral squamous cell carcinoma: the role of cognitive and psychological variables. Int J Oral Sci (2013) 0.86
Maxillofacial prosthesis in a palliative care for terminally ill patient with squamous cell carcinoma. BMJ Case Rep (2013) 0.83
Palliative and end of life care issues of carcinoma thyroid patient. Indian J Palliat Care (2012) 0.80
Influences of cancer symptom knowledge, beliefs and barriers on cancer symptom presentation in relation to socioeconomic deprivation: a systematic review. BMC Cancer (2015) 0.77
Patient related factors associated with delayed reporting in oral cavity and oropharyngeal cancer. Int J Prev Med (2014) 0.76
Can the diagnostic delay of oral cancer by healthcare practitioners be prevented? Who should bear the blame of delay? J Family Community Med (2015) 0.75
Analysis of angiogenic markers in oral squamous cell carcinoma-gene and protein expression. Head Face Med (2015) 0.75
Patient's delay in oral cancer: A systematic review. Community Dent Oral Epidemiol (2006) 1.82
Major and minor salivary gland tumors. Crit Rev Oncol Hematol (2009) 1.77
Facial reconstruction in the developing world: a complicated matter. Br J Oral Maxillofac Surg (2010) 1.48
Integrated media presentation in multidisciplinary head and neck oncology meetings. Eur Arch Otorhinolaryngol (2008) 1.38
Antibiotic prophylaxis of endocarditis: the rest of the world and NICE. J R Soc Med (2011) 1.24
Outcome of minimally invasive management of salivary calculi in 4,691 patients. Laryngoscope (2009) 1.20
Barriers and triggers to seeking help for potentially malignant oral symptoms: implications for interventions. J Public Health Dent (2009) 1.12
Illness and treatment beliefs in head and neck cancer: is Leventhal's common sense model a useful framework for determining changes in outcomes over time? J Psychosom Res (2007) 1.07
Associations between quality of life, coping styles, optimism, and anxiety and depression in pretreatment patients with head and neck cancer. Head Neck (2011) 1.00
Development and preliminary validation of a new measure to assess satisfaction with information among head and neck cancer patients: the satisfaction with cancer information profile (SCIP). Head Neck (2006) 0.97
Assessing the psychological predictors of benefit finding in patients with head and neck cancer. Psychooncology (2011) 0.94
Intraoral duct ligation without inclusion of the parasympathetic nerve supply induces rat submandibular gland atrophy. Int J Exp Pathol (2006) 0.93
The process of symptom appraisal: cognitive and emotional responses to detecting potentially malignant oral symptoms. J Psychosom Res (2007) 0.93
Can we predict which head and neck cancer survivors develop fears of recurrence? J Psychosom Res (2008) 0.92
Recovery of rat submandibular salivary gland function following removal of obstruction: a sialometrical and sialochemical study. Int J Exp Pathol (2006) 0.88
Balloon dilatation of salivary duct strictures: report on 36 treated glands. Cardiovasc Intervent Radiol (2002) 0.87
Incidence of salivary gland neoplasms in a defined UK population. Br J Oral Maxillofac Surg (2012) 0.87
Implications of a positive sentinel node in oral squamous cell carcinoma. Head Neck (2012) 0.85
Salivary gland disease. Front Oral Biol (2010) 0.85
Copy number and loss of heterozygosity detected by SNP array of formalin-fixed tissues using whole-genome amplification. PLoS One (2011) 0.85
Sentinel Node in Oral Cancer: The Nuclear Medicine Aspects. A Survey from the Sentinel European Node Trial. Clin Nucl Med (2016) 0.82
Factors influencing the outcome of extracorporeal shock wave lithotripsy in the management of salivary calculi. Laryngoscope (2010) 0.82
The relative cost of sentinel lymph node biopsy in early oral cancer. J Craniomaxillofac Surg (2013) 0.82
Minimally invasive options for salivary calculi. Laryngoscope (2012) 0.80
Benign parotid tumours. BMJ (2004) 0.80
Joint practice guidelines for radionuclide lymphoscintigraphy for sentinel node localization in oral/oropharyngeal squamous cell carcinoma. Eur J Nucl Med Mol Imaging (2009) 0.80
Validation of PET imaging by alignment to histology slices. Med Image Comput Comput Assist Interv (2005) 0.78
Sentinel lymph node biopsy for T1/T2 oral cavity squamous cell carcinoma--a prospective case series. Ann Surg Oncol (2012) 0.78
To retrieve or not to retrieve the coronectomy root--the clinical dilemma. Dent Update (2013) 0.78
Transoral removal of hiloparenchymal submandibular calculi: a long-term clinical experience. Eur Arch Otorhinolaryngol (2011) 0.77
Pilot study to estimate the accuracy of mouth self-examination in an at-risk group. Head Neck (2010) 0.77
Early outcome of facial reconstructive surgery abroad: a comparative study. Eur J Plast Surg (2010) 0.77
Long-term outcome after intraoral removal of large submandibular gland calculi. Laryngoscope (2010) 0.76
Unerupted teeth associated with dentigerous cysts and treated with coronectomy: mini case series. Br J Oral Maxillofac Surg (2013) 0.76
Three-dimensional imaging and navigated sentinel node biopsy for primary parotid malignancy: new application in parotid cancer management. Head Neck (2014) 0.76
Atypical fulminating dental nfections. Dent Update (2008) 0.75
Epidemiology of salivary gland infections. Oral Maxillofac Surg Clin North Am (2009) 0.75
Reconstruction of segmental hemi-mandibular defects using soft tissue flaps in patients with severe comorbidity and advanced head and neck cancer. J Egypt Natl Canc Inst (2008) 0.75
Simultaneous and differential fronto-orbital and midface distraction osteogenesis for syndromic craniosynostosis using rigid external distractor II. J Craniofac Surg (2012) 0.75
Minimally invasive radiologically guided intervention for the treatment of salivary calculi. Cardiovasc Intervent Radiol (2002) 0.75
Advances in the treatment of salivary gland disease. Practitioner (2006) 0.75